Meet Dr. Araz Marachelian, MD, MS. An attending Physician at Children’s Hospital Los Angeles, Hematology, Oncology and Blood and Marrow Transplantation Department.
Dr. Araz Marachelian is a board certified pediatric oncologist whose clinical and research focus is neuroblastoma. Dr. Marachelian completed her pediatric oncology fellowship training at CHLA with an emphasis on investigation at the New Approaches to Neuroblastoma therapy Consortium. She also obtained a masters in clinical investigation at USC. Dr. Marachelian is the director of the clinical neuroblastoma program, and has also been the medical director of Operations of the NANT consortium since 2010. In this role, she is integrally involved in protocol development at the NANT consortium and oversees the conduct of studies and their completion. Her research emphasis is on studying new immunotherapeutic approaches to the treatment of neuroblastoma as well as in studying minimal disease detection. Dr. Marachelian chairs clinical trials within the NANT consortium, and leads the post consolidation task force in Children’s Oncology Group.
Dr. Marachelian is the head of the New Approaches to Neuroblastoma Therapy Consortium (NANT) which seeks to improve the survival rates and quality of life for children with this aggressive cancer. Her research focuses on immunotherapies and minimal residual disease detection with an aim toward identifying novel agents that both target the cancer cells and the surrounding environment of normal cells that support tumor growth.